[ad_1]
The SAM informed the vaccination coordinating centers that the vaccination process could continue.
On Wednesday, the Ministry of Health (SAM) was informed that on January 12. The cold chain may have been damaged during transportation by delivering the vaccine from two pharmaceutical companies BioNTech and Pfizer to the coordinating centers: the Kaunas Clinic of the Lithuanian University of Health Sciences and the Republican Panevėžys Hospital, media reported.
SAM immediately informed the coordinator to temporarily suspend vaccination with this batch of vaccine. The State Agency for the Control of Medicines (IARC) was instructed to investigate before Wednesday night whether the vaccine had been affected by temperature fluctuations during transport. SAM provided the data to the Pfizer representative office in Lithuania for the manufacturer to conclude whether the fluctuations found did not affect the quality of the vaccine.
Conclusions from IWT and Pfizer’s representative office in Lithuania are still awaited today on whether further use of these doses of vaccine is possible. The aforementioned shipment contained 4,680 doses of COVID-19 vaccine: 2,340 doses of vaccine for the Kaunas and Panevėžys regions.
According to the preliminary assessment of the Pfizer representative office in Lithuania, the temperature drift during transport was within the allowed limits and had no effect on the vaccines.
[ad_2]
